OCUL — Ocular Therapeutix Balance Sheet
0.000.00%
- $2.50bn
- $2.18bn
- $63.72m
Annual balance sheet for Ocular Therapeutix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 228 | 164 | 102 | 196 | 392 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12.3 | 21.1 | 21.3 | 26.2 | 32.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 246 | 191 | 130 | 232 | 441 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 13.9 | 11.8 | 17.9 | 18.2 | 15.3 |
| Other Long Term Assets | |||||
| Total Assets | 262 | 205 | 149 | 252 | 458 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 26.7 | 26.3 | 31.4 | 34.9 | 41.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 186 | 117 | 114 | 161 | 143 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 76.1 | 88 | 35.4 | 91.1 | 315 |
| Total Liabilities & Shareholders' Equity | 262 | 205 | 149 | 252 | 458 |
| Total Common Shares Outstanding |